Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR2 | O43614 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CTSK | P43235 | 8/20 | 0.33 |
| ▸ | CTSS | P25774 | 4/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CTSL | P07711 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28580336 | 1.00 | HCRTR2 (0.39) | HCRTR2CA1CA2CA7CTSK | |
| SCHEMBL13725768 | 0.88 | HCRTR2 (0.40) | HCRTR2CA1CA2CA7CTSK | |
| SCHEMBL28588817 | 0.88 | HCRTR2 (0.40) | HCRTR2CA1CA2CA7CTSK | |
| SCHEMBL13528024 | 0.81 | HCRTR2 (0.40) | HCRTR2CA1CA2CA7CTSK | |
| SCHEMBL28575650 | 0.80 | HCRTR2 (0.37) | HCRTR2CA1CA2CA7CTSK | |
| SCHEMBL28599433 | 0.79 | SCN9A (0.36) | HCRTR2 | |
| SCHEMBL28599432 | 0.79 | SCN9A (0.36) | HCRTR2 | |
| SCHEMBL14163632 | 0.79 | BACE1 (0.39) | CTSKCTSS | |
| SCHEMBL20263095 | 0.77 | HCRTR2 (0.35) | HCRTR2 | |
| SCHEMBL20263097 | 0.77 | HCRTR2 (0.35) | HCRTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107709301-B | Pyrazole derivative or pharmacologically acceptable salt thereof | 橘生药品工业株式会社 | 2021-06-22 | — | — | CN | disclosed |